KDA Group Inc (KDA) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of KDA Group Inc C$0.02, price C$0.07, upside -64.4%, quality 16 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch KDA Group Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
KDA Group Inc., together with its subsidiaries, provides technological and operational efficiency solutions for both the general and specialized health sectors in Canada.
Show more
KDA Group Inc., together with its subsidiaries, provides technological and operational efficiency solutions for both the general and specialized health sectors in Canada. The company offers Adherize+, which is an intelligent patient engagement platform designed to monitor treatment adherence and provide tailored interventions; Medherize, a specialized module of Adherize+, focuses on patients undergoing complex therapies such as oral oncology treatments; KRx is an advanced electronic prescription platform for medical clinics; and CareMedic is digital health record and care coordination platform. The company was formerly known as AlliancePharma Inc. and changed its name to KDA Group Inc. in February 2017. KDA Group Inc. is headquartered in Thetford Mines, Canada.
Stock analysis
KDA Group Inc (KDA) currently trades at C$0.0700, while our model-based Fair Value estimate is C$0.0249, implying the stock looks roughly 181.1% overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 80/100, which puts the evidence level at low.
Quality & growth
The Quality Score stands at 16/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
KDA Group Inc reported revenue of C$165K in FY2025 versus C$24.4M in FY2021, a compound −71.3%/yr. Reported net income was −C$8.0M in FY2025.
Key figures
Market cap C$13.5M (≈ $9.6M) · P/S ratio 44.2 · EPS (TTM) C$−0.0400 · Return on equity −88.2% · Return on assets (EBIT) −23.3% · Operating margin −1,065% · Revenue (TTM) C$317K · Revenue growth (YoY) +82.4%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (medium confidence).
What moves the price
The share trades about 74% below its 52-week high and 27% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −45% fair-value upside, at −64%, KDA screens richer than that median.
Fair Value models
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.0/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+12.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−82.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−62.7%
Start year 2020 (pandemic). Over 10 years: −29.6% a year
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−24.8%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−0.4% (2020) → −5,407.8% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 134 stocks
Beats the industry median on 2/7 measures
Overall it trails its industry peers.
Valuation
Quality Score19 · Bottom 25%
Fair Value upside−64% · Below median
Profitability
Return on assets−45% · Bottom 25%
Growth and dividend
Revenue growth82% · Top 25%
Balance sheet
Debt / equity0.06× · Above median
Valuation Multiplesvs Health Information Services median · lower = cheaper
P/B0.88× · Cheapest 25%
P/S (TTM)30.28× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 3
FUTURE (revenue growth)100· sector 34
PAST (return on equity)0· sector 5
HEALTH (low debt)97· sector 98
DIVIDEND (yield)0· sector 48
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "KDA Group Inc Fair Value". https://www.fairvalue-calculator.com/stock/KDA
Frequently asked questions
Is KDA Group Inc (KDA) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of C$0.0249 versus a price of C$0.0700, about −64% upside (overvalued).
What is the fair value of KDA?
Our model-based fair value for KDA Group Inc is C$0.0249 (as of Sep 23, 2026), built from audited fundamentals. The current price: C$0.0700.
What is the quality score of KDA?
KDA Group Inc has a Quality Score of 16/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for KDA Group Inc (KDA)?
Our model-based price target is the fair value of C$0.0249 (as of Sep 23, 2026) from 1 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the KDA Group Inc stock forecast for 2026?
Our models put fair value at C$0.0249, about −64% upside versus a price of C$0.0700 (overvalued). The calculation is refreshed regularly with new filings.
What is the revenue of KDA Group Inc (KDA)?
KDA Group Inc reported trailing-twelve-month revenue of about C$317K (latest available figure, as of Sep 23, 2026).
What is the intrinsic value of KDA Group Inc (KDA)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For KDA Group Inc it is C$0.0249 per share (as of Sep 23, 2026), against a price of C$0.0700. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is KDA Group Inc stock overvalued or undervalued in 2026?
As of Sep 23, 2026, KDA trades above its calculated fair value: price C$0.0700, fair value C$0.0249, a gap of about −64% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of KDA?
No. The price is what the market pays today (C$0.0700); the fair value is what the company's own numbers justify (C$0.0249). For KDA Group Inc the two are C$0.0451 per share apart. That gap is exactly why we show both numbers side by side.
How much is KDA Group Inc worth?
The market values KDA Group Inc at about C$13.5M (market capitalisation, as of Sep 23, 2026). Per share that is C$0.0700; our models calculate a fair value of C$0.0249 per share.
How solid is the balance sheet of KDA Group Inc (KDA)?
Balance-sheet figures for KDA Group Inc (as of Sep 23, 2026): return on equity −88.2%, debt of 0.06 per unit of equity. They feed the Quality Score of 16/100, which measures business quality independently of the share price.
How far is KDA from its 52-week high?
KDA Group Inc trades at C$0.0700, about 74% below its 52-week high of C$0.2650 and 27% above the low of C$0.0550 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of C$0.0249 is for.
Which stocks are comparable to KDA Group Inc?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, HealthEquity, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is KDA Group Inc stock attractive at the current price?
The data as of Sep 23, 2026: price C$0.0700, calculated fair value C$0.0249 (−64%), Quality Score 16/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of KDA calculated?
We run KDA Group Inc through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of C$0.0249, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. KDA Group Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of KDA Group Inc (KDA)?
The closing price on Sep 23, 2026 was C$0.0700. Our model-based fair value is C$0.0249, about −64% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with KDA Group Inc right now?
Weak quality (16/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of KDA Group Inc
How large is the market capitalisation of KDA Group Inc (KDA)?
The market capitalisation of KDA Group Inc is C$13.5M (≈ $9.6M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of KDA Group Inc (KDA)?
The price-to-sales ratio of KDA Group Inc is 44.2 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of KDA Group Inc (KDA)?
Earnings per share at KDA Group Inc are C$−0.0400. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of KDA Group Inc (KDA)?
The return on equity (ROE) of KDA Group Inc is −88.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of KDA Group Inc (KDA)?
On an EBIT basis the return on assets of KDA Group Inc is −23.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of KDA Group Inc (KDA)?
The operating margin of KDA Group Inc is −1,065% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at KDA Group Inc (KDA)?
Revenue at KDA Group Inc is growing +82.4% versus a year earlier (3y avg −82.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does KDA Group Inc (KDA) generate?
The free cash flow of KDA Group Inc is −C$3.7M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does KDA Group Inc (KDA) carry?
The net debt of KDA Group Inc is C$516K (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch KDA Group Inc in the live analysis
One click puts KDA Group Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
